Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A112C8 | ISIN: FR0010120402 | Ticker-Symbol: 941
Stuttgart
06.06.25 | 08:09
0,271 Euro
-1,09 % -0,003
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
THERACLION Chart 1 Jahr
5-Tage-Chart
THERACLION 5-Tage-Chart
RealtimeGeldBriefZeit
0,2860,28817:20

Aktuelle News zur THERACLION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.04.Theraclion Announces Financial Results 2024 and Reviews Progress 315Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces...
► Artikel lesen
26.03.Theraclion Completes Its Previous Financing Round With an Additional Convertible Bonds Issuance428Issuance of warrants for bonds convertible into shares, in accordance with Theraclion's commitment, to investors who have requested them, for a maximum amount of 580,000 euros. 290,000...
► Artikel lesen
20.02.Theraclion Secures Financing From Its Historical Shareholders Through a Convertible Bond Loan564Reserved issuance of warrants for convertible bonds based on a fixed price per share of 0.20 euros (without discount), for a maximum amount of €6 million, benefiting Furui and Unigestion, the...
► Artikel lesen
11.02.Theraclion Announces Treatment of First Patients With New SONOVEIN 'SpeedPulse' Feature Accelerating Treatment391Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces...
► Artikel lesen
07.02.Theraclion: Publication of Adjusted Accounts for the First Half of 2024493Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment...
► Artikel lesen
06.01.Theraclion Reviews Its 2024 Achievements320Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment...
► Artikel lesen
30.10.24Theraclion Announces Major Advances and Reports First-Half Financial Results491On the strength of its progress on its 2023 and 2024 priorities (access to the US market, R&D and China), Theraclion is planning its commercial ramp-up for 2025 and 2026. Pivotal study for...
► Artikel lesen
06.09.24Theraclion Confirms Strong Mid-Year Achievements456Main focus: Access to the U.S. market, R&D and China. Key achievements in H1 2024: FDA pivotal study: treatments completed in June on schedule Promising R&D progress in product features...
► Artikel lesen
THERACLION Aktie jetzt für 0€ handeln
24.06.24SONOVEIN FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule674Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE) innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy...
► Artikel lesen
06.06.24Theraclion: SONOVEIN Highlighted in Top Medical Conferences and Scientific Journal576Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces...
► Artikel lesen
10 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1